Table 3 Demographics and audiologic features of patients in Group C and Group D.

From: The therapeutic effect of hyperbaric oxygen therapy in patients with severe to profound idiopathic sudden sensorineural hearing loss

Characteristic

Group C

(Oral steroid + ITS + HBOT)

(n = 37)

Group D

(Oral steroid + ITS)

(n = 49)

p-value

Mean age (years)

45.3 ± 13.1

50.0 ± 14.4

0.121a

Gender (Male : Female)

22:15

31:18

0.719d

Side (Right : left)

24:13

21:28

0.043d*

Time from symptom onset of SSNHL to treatment (days)

2.9 ± 2.6

3.0 ± 2.8

0.976a

Initial PTA (dB)

98.7 ± 11.3

100.8 ± 12.4

0.417a

 80–89 dB SSNHL

11 (29.7%)

13 (26.5%)

0.743d

 90–99 dB SSNHL

9 (24.3%)

11 (22.4%)

0.838d

  ≥ 100 dB SSNHL

17 (45.9%)

25 (51.0%)

0.641d

Rate of diabetes (n [%])

9 (24.3%)

10 (20.4%)

0.665d

  1. HBOT, Hyperbaric oxygen therapy; SSNHL, Sudden sensorineural hearing loss; PTA, pure-tone average; ITS, Intratympanic steroids.
  2. Data are presented as mean ± standard error of the mean. * p < 0.05.
  3. ap-value were calculated by student-T test.
  4. dp-value were calculated by chi-square test.
Back to article page